Polarean Imaging 考虑退市以降低成本，以应对交易低迷和估值被低估的情况。 Polarean Imaging considers delisting to reduce costs amid low trading and undervaluation.

Polarean Imaging PLC 正在审查战略选择，包括从 AIM 退市，以在交易量低和估值过低的情况下削减成本并提高灵活性。 Polarean Imaging PLC is reviewing strategic options, including delisting from AIM to cut costs and boost flexibility amid low trading volumes and undervaluation. 源流生物科学公司为SIRT6型变体获得暂时的欧洲专利保护,该变体针对NASH, 推进其长寿和代谢疾病研究。 Genflow Biosciences secured provisional European patent protection for a SIRT6 variant targeting NASH, advancing its longevity and metabolic disease research. MedPal AI在Swaffham启动了一个24/7的自动药房,每月与AI和机器人一起处理10万多处方。 MedPal AI launched a 24/7 automated pharmacy in Swaffham, processing over 100,000 prescriptions monthly with AI and robotics. 其他最新消息包括绿色能源、黄金价格和公司收入方面的积极变化,而更广泛的市场趋势反映了投资者的谨慎态度。 Other updates include positive moves in green energy, gold prices, and corporate earnings, while broader market trends reflect cautious investor sentiment.